Medicare Enrolled

Dr. Genevieve Pate, ARNP

Nurse Practitioner - Family · Quilcene, WA
Low-engagement
294843 US HIGHWAY 101, Quilcene, WA 98376
3603853991
In practice since 2017 (8 years)
NPI: 1376056622 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pate from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pate? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pate

Dr. Genevieve Pate is a nurse practitioner - family in Quilcene, WA, with 8 years of NPI registration.

Between the years covered by Open Payments, Dr. Pate received a total of $4,149 from 30 pharmaceutical and/or device companies across 213 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pate is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice $4,149 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$4,149
Total received (2021-2024)
Avg $1,037/year across 4 years
Top 4% in WA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
213
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,149 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$33
2023
$142
2022
$1,728
2021
$2,247

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$33
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$641
AbbVie Inc.
$477
Lilly USA, LLC
$355
AstraZeneca Pharmaceuticals LP
$286
ABBVIE INC.
$262
Janssen Pharmaceuticals, Inc
$236
Amgen Inc.
$231
Biohaven Pharmaceutical Holding Company Ltd.
$172
Antares Pharma, Inc.
$165
GlaxoSmithKline, LLC.
$153
Amarin Pharma Inc.
$151
Boehringer Ingelheim Pharmaceuticals, Inc.
$131
Biohaven Pharmaceuticals, Inc.
$123
Eisai Inc.
$88
Esperion Therapeutics, Inc.
$87
Abbott Laboratories
$79
Bayer HealthCare Pharmaceuticals Inc.
$66
Mannkind Corporation
$59
Teva Pharmaceuticals USA, Inc.
$58
Sunovion Pharmaceuticals Inc.
$51
Novartis Pharmaceuticals Corporation
$48
PFIZER INC.
$45
Astellas Pharma US Inc
$39
ARBOR PHARMACEUTICALS, INC.
$38
JAZZ PHARMACEUTICALS INC.
$24
IDORSIA PHARMACEUTICALS US INC
$20
Nestle HealthCare Nutrition Inc.
$19
Allergan, Inc.
$17
Acerus Pharmaceuticals Corporation
$15
SANOFI-AVENTIS U.S. LLC
$13
Top 3 companies account for 35.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AJOVY · Aimovig · BOTOX · CREON · Dayvigo · ELIQUIS · EMGALITY · EVENITY · Edarbi · FARXIGA · FREESTYLE LIBRE 2 · GEMTESA · JARDIANCE · Kerendia · LEQVIO · LINZESS · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NOCDURNA · NURTEC ODT · Natesto · Otezla · Ozempic · QULIPTA · QUVIVIQ · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA 100/33 · STIOLTO RESPIMAT · SUNOSI · SYNJARDY · SYNTHROID · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VRAYLAR · Vascepa · Wegovy · XARELTO · XYOSTED · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for nurse practitioner - family in WA.

Looking for a nurse practitioner - family in Quilcene?
Compare family nurse practitioners in the Quilcene area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
189
Per 100K population
567.3
County median income
$71,143
Nearest hospital
JEFFERSON HEALTHCARE
13.5 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pate is a nurse practitioner - family, with low-engagement industry engagement in the top 4% of WA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Pate receive payments from pharmaceutical companies?
Yes. Dr. Pate received a total of $4,149 from 30 companies across 213 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Pate) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Family Nurse Practitioners in Quilcene
Browse family nurse practitioners in Quilcene ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in WA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in WA
Which WA family nurse practitioners receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →